Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Origin Therapeutics (CSE: ORIG) is an actively-managed investment issuer providing investors with diverse exposure to the psychedelic industry. Our investment mandate is simple: focus on companies with an exemplary management team and exponential growth profile.A Global Psychedelic-Focused Investment Opportunity Origin Therapeutics is an actively-managed investment issuer providing investors with a diverse exposure to the p...
Origin Therapeutics (CSE: ORIG) is an actively-managed investment issuer providing investors with diverse exposure to the psychedelic industry. Our investment mandate is simple: focus on companies with an exemplary management team and exponential growth profile.A Global Psychedelic-Focused Investment Opportunity Origin Therapeutics is an actively-managed investment issuer providing investors with a diverse exposure to the psychedelic industry.

List your booth number for exhibitions, ask us